Wockhardt Q3 Results
- BSE: 532300
- NSE: WOCKPHARMA
- ISIN: INE049B01025
- Sector: Biotechnology & Drugs
BSE
2,040
118.10 (6.14%)
118.10 (6.14%)Volume1.93 L
Updated: Wed 17 Jun, 2026 | 13:23:52
NSE
2,017.5098.30 (5.12%)
98.30 (5.12%)Volume1.60 M
Updated: Wed 17 Jun, 2026 | 13:08:53
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Wockhardt Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 790.00 | 734.00 | 17.04% | 704.00 | 16.18% |
| Depreciation/ Amortization | 65.00 | 55.00 | 22.64% | 55.00 | 18.18% |
| Operating Income | 98.00 | 75.00 | -8.41% | -3.00 | 139.02% |
| Net Income | 59.00 | -22.00 | -24.36% | -83.00 | 321.43% |
| Other Operating Expenses Total | 217.00 | 221.00 | 6.90% | 195.00 | 9.05% |
| Net Income Before Taxes | 67.00 | -9.00 | -26.37% | -87.00 | 219.05% |
| Total Revenue | 888.00 | 809.00 | 13.55% | 701.00 | 23.16% |
| Selling/ General/ Admin Expenses Total | 181.00 | 161.00 | -2.69% | 152.00 | 10.37% |
| Diluted Normalized EPS | 4.17 | -1.47 | -13.37% | -5.75 | 357.92% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.